Literature DB >> 2512648

Anxiety disorders in a French general psychiatric outpatient sample. Comparison between DSM-III and DSM-IIIR criteria.

J P Lepine, P Pariente, J P Boulenger, P Hardy, E Zarifian, T Lemperiere, J Lellouch.   

Abstract

In a general psychiatric outpatient sample (n = 1271) gathered through a cross-national French survey, anxiety and somatoform syndromes were assessed according to DSM-III and DMS-III-revised criteria. Lifetime and one-month prevalence rates in this population are provided and the high level of comorbidity between the anxiety syndromes is noted. The patient symptom profiles for panic syndrome, simple attacks, agoraphobia and generalized anxiety are displayed. The conspicuous consequences of the modifications brought in by the Revision-anticipatory anxiety in panic syndrome, and restricted period criteria for generalized anxiety- are discussed, with the conclusion that more field study assessment is required before further revision.

Entities:  

Mesh:

Year:  1989        PMID: 2512648     DOI: 10.1007/bf01788033

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  19 in total

1.  Contemporary conversion reactions : a clinical study.

Authors:  F J ZIEGLER; J B IMBODEN; E MEYER
Journal:  Am J Psychiatry       Date:  1960-04       Impact factor: 18.112

2.  Sex, age, and the diagnosis of hysteria (Briquet's syndrome).

Authors:  S B Guze; R A Woodruff; P J Clayton
Journal:  Am J Psychiatry       Date:  1972-12       Impact factor: 18.112

3.  Neurosis divisible?

Authors:  P Tyrer
Journal:  Lancet       Date:  1985-03-23       Impact factor: 79.321

4.  Classification of anxiety disorders: a critique of DSM-III.

Authors:  P Tyrer
Journal:  J Affect Disord       Date:  1986 Sep-Oct       Impact factor: 4.839

5.  The epidemiology of panic attacks and panic disorder. Results of three community surveys.

Authors:  M R Von Korff; W W Eaton; P M Keyl
Journal:  Am J Epidemiol       Date:  1985-12       Impact factor: 4.897

Review 6.  The epidemiology of anxiety and panic disorders: an update.

Authors:  M M Weissman; K R Merikangas
Journal:  J Clin Psychiatry       Date:  1986-06       Impact factor: 4.384

7.  The classification of anxiety and hysterical states. Part II. Toward a more heuristic classification.

Authors:  D V Sheehan; K H Sheehan
Journal:  J Clin Psychopharmacol       Date:  1982-12       Impact factor: 3.153

8.  The Zurich Study. V. Anxiety and phobia in young adults.

Authors:  J Angst; A Dobler-Mikola
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

9.  A comparison of panic disorder and agoraphobia with panic attacks.

Authors:  B A Thyer; J Himle; G C Curtis; O G Cameron; R M Nesse
Journal:  Compr Psychiatry       Date:  1985 Mar-Apr       Impact factor: 3.735

10.  Symptom profiles of patients with DSM-III anxiety disorders.

Authors:  O G Cameron; B A Thyer; R M Nesse; G C Curtis
Journal:  Am J Psychiatry       Date:  1986-09       Impact factor: 18.112

View more
  4 in total

1.  The epidemiology of anxiety disorders: a review.

Authors:  Patrick Martin
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

2.  Epidemiology of anxiety disorders in the 21st century.

Authors:  Borwin Bandelow; Sophie Michaelis
Journal:  Dialogues Clin Neurosci       Date:  2015-09       Impact factor: 5.986

3.  Mindfulness-Based Interventions and Body Awareness.

Authors:  Marbella Pérez-Peña; Jessica Notermans; Olivier Desmedt; Katleen Van der Gucht; Pierre Philippot
Journal:  Brain Sci       Date:  2022-02-18

4.  Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey.

Authors:  Christelle Nguyen; Brigitte Ranque; Thierry Baubet; Alice Bérezné; Caroline Mestre-Stanislas; François Rannou; Agathe Papelard; Sandrine Morell-Dubois; Michel Revel; Marie-Rose Moro; Loïc Guillevin; Serge Poiraudeau; Luc Mouthon
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.